SCHEMBL4434723

SCHEMBL4434723

CN1CC(C(=O)O)c2cc(NS(=O)(=O)c3cc(Cl)cc(Cl)c3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.46
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
PGR P06401 1/20 0.42
PSEN1 P49768 4/20 0.41
PSEN2 P49810 4/20 0.41
APH1B Q8WW43 4/20 0.41
NCSTN Q92542 4/20 0.41
APH1A Q96BI3 4/20 0.41
PSENEN Q9NZ42 4/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 3/20 0.40
ACLY P53396 4/20 0.40
PKM P14618 1/20 0.39
TP53 P04637 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2844662 0.78 PGR (0.40) HTR6POLBKDM4ELMNAPGR
SCHEMBL2851271 0.75 HTR6 (0.44) HTR6POLBPGRPSEN1PSEN2
SCHEMBL2852650 0.74 HTR6 (0.39) HTR6POLBKDM4ELMNAPGR
SCHEMBL2852648 0.73 STS (0.45) HTR6PGRPSEN1PSEN2APH1B
SCHEMBL3032827 0.70 CPT1A (0.38) HTR6POLBPGRPSEN1PSEN2
SCHEMBL3039604 0.68 PKM (0.74) HTR6POLBLMNAPKM
SCHEMBL2930103 0.68 CYP3A4 (0.43) HTR6PGRPSEN1PSEN2APH1B
SCHEMBL2848835 0.67 POLB (0.40) POLBKDM4ELMNAMAPTPKM
SCHEMBL2844660 0.67 ADRB2 (0.66) HTR6LMNAPKMTP53
SCHEMBL4197383 0.66 CYP3A4 (0.47) HTR6LMNAPGRPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125718-A2 NEW SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-12-02 EP disclosed
WO-2008113760-A2 ARYLSULPHONYGLYCINE DERIVATIVES AS SUPPRESSORS OF THE INTERACTION OF GLYCOGEN PHOSPHORYLASE A WITH THE GL SUBUNIT OF GLYCOGEN-ASSOCIATED PROTEIN PHOSPHATASE 1 (PPL) FOR THE TREATMENT OF METABOLIC DISORDERS, PARTICULARY DIABETES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-09-25 WO disclosed